| Zionsville Holistic Chiropractic & Wellness Center | |
|
1620 W Oak St Suite 100 Zionsville IN 46077-1969 | |
| (317) 733-9630 | |
| (317) 733-9631 |
| Full Name | Zionsville Holistic Chiropractic & Wellness Center |
|---|---|
| Speciality | Clinic/Center |
| Location | 1620 W Oak St, Zionsville, Indiana |
| Authorized Official Name and Position | Gerald L. Whalen (PRESIDENT) |
| Authorized Official Contact | 3177339630 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Zionsville Holistic Chiropractic & Wellness Center 1620 W Oak St Suite 100 Zionsville IN 46077-1969 Ph: (317) 733-9630 | Zionsville Holistic Chiropractic & Wellness Center 1620 W Oak St Suite 100 Zionsville IN 46077-1969 Ph: (317) 733-9630 |
| NPI Number | 1083890487 |
|---|---|
| Provider Enumeration Date | 01/15/2008 |
| Last Update Date | 08/14/2020 |
| Medicare PECOS PAC ID | 8426117482 |
|---|---|
| Medicare Enrollment ID | O20081105000337 |
News Archive
The targeted cancer drug erlotinib has comparable efficacy to chemotherapy, and is better tolerated, in hard-to-treat cases where a patient's cancer has progressed quickly after treatment with first-line therapy, the results of a new phase III trial show.
The Medical Research Council (MRC), the National Institute for Health Research (NIHR) and the health research departments in Northern Ireland, Scotland and Wales have launched a joint initiative of more than £6millon to identify small carefully defined groups of patients to help researchers detect, treat or prevent diseases.
Overall mortality rates from the end of 2007 to the beginning of 2010 at Bay Medical Center in Panama City, Florida have dropped from 3.4 to 2.1. A 1.3-point drop represents a huge reduction for any hospital and translates into lives saved.
An important finding, which could eventually lead to a new therapeutic approach for treating autoimmune and inflammatory diseases such as rheumatoid arthritis, colitis, psoriasis and others, was announced by researchers at the La Jolla Institute for Allergy & Immunology (LIAI).
Researchers from The University of Texas MD Anderson Cancer Center reported study results showing that initial treatment with the PARP inhibitor veliparib in combination with chemotherapy significantly increased progression-free survival for patients with newly diagnosed, metastatic high-grade serous ovarian cancer, according to the results of the VELIA trial.
› Verified 6 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083890487 | NPI | - | NPPES |
| 100256390A | Medicaid | IN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261Q00000X | Clinic/center | 51000102A (Indiana) | Primary |
| Provider Name | Gerald L Whalen |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1720180250 PECOS PAC ID: 3173682135 Enrollment ID: I20081105000322 |
News Archive
The targeted cancer drug erlotinib has comparable efficacy to chemotherapy, and is better tolerated, in hard-to-treat cases where a patient's cancer has progressed quickly after treatment with first-line therapy, the results of a new phase III trial show.
The Medical Research Council (MRC), the National Institute for Health Research (NIHR) and the health research departments in Northern Ireland, Scotland and Wales have launched a joint initiative of more than £6millon to identify small carefully defined groups of patients to help researchers detect, treat or prevent diseases.
Overall mortality rates from the end of 2007 to the beginning of 2010 at Bay Medical Center in Panama City, Florida have dropped from 3.4 to 2.1. A 1.3-point drop represents a huge reduction for any hospital and translates into lives saved.
An important finding, which could eventually lead to a new therapeutic approach for treating autoimmune and inflammatory diseases such as rheumatoid arthritis, colitis, psoriasis and others, was announced by researchers at the La Jolla Institute for Allergy & Immunology (LIAI).
Researchers from The University of Texas MD Anderson Cancer Center reported study results showing that initial treatment with the PARP inhibitor veliparib in combination with chemotherapy significantly increased progression-free survival for patients with newly diagnosed, metastatic high-grade serous ovarian cancer, according to the results of the VELIA trial.
› Verified 6 days ago
News Archive
The targeted cancer drug erlotinib has comparable efficacy to chemotherapy, and is better tolerated, in hard-to-treat cases where a patient's cancer has progressed quickly after treatment with first-line therapy, the results of a new phase III trial show.
The Medical Research Council (MRC), the National Institute for Health Research (NIHR) and the health research departments in Northern Ireland, Scotland and Wales have launched a joint initiative of more than £6millon to identify small carefully defined groups of patients to help researchers detect, treat or prevent diseases.
Overall mortality rates from the end of 2007 to the beginning of 2010 at Bay Medical Center in Panama City, Florida have dropped from 3.4 to 2.1. A 1.3-point drop represents a huge reduction for any hospital and translates into lives saved.
An important finding, which could eventually lead to a new therapeutic approach for treating autoimmune and inflammatory diseases such as rheumatoid arthritis, colitis, psoriasis and others, was announced by researchers at the La Jolla Institute for Allergy & Immunology (LIAI).
Researchers from The University of Texas MD Anderson Cancer Center reported study results showing that initial treatment with the PARP inhibitor veliparib in combination with chemotherapy significantly increased progression-free survival for patients with newly diagnosed, metastatic high-grade serous ovarian cancer, according to the results of the VELIA trial.
› Verified 6 days ago
Anderson Chiropractic Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1227 W Oak St, Zionsville, IN 46077 Phone: 317-873-1000 Fax: 317-873-0401 | |
St. Vincent Medical Group, Inc. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 10801 N Michigan Rd Ste 205, Zionsville, IN 46077 Phone: 317-733-1829 | |
Monarch Restorative Medicine Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 9601 Irishmans Run Ln, Zionsville, IN 46077 Phone: 309-265-6864 | |
Emd Healthcare, Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 6582 W Deerfield Dr, Zionsville, IN 46077 Phone: 317-800-3355 | |
Zionsville Family Practice Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 55 Brendon Way, Ste 300, Zionsville, IN 46077 Phone: 317-873-3088 Fax: 317-873-3050 | |
Westside Adult Medicine, Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 675 S Ford Rd, Zionsville, IN 46077 Phone: 317-873-5205 Fax: 317-858-4168 |